These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29124986)

  • 1. Development of zolmitriptan transfersomes by Box-Behnken design for nasal delivery: in vitro and in vivo evaluation.
    Pitta SK; Dudhipala N; Narala A; Veerabrahma K
    Drug Dev Ind Pharm; 2018 Mar; 44(3):484-492. PubMed ID: 29124986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency.
    Abd-Elal RM; Shamma RN; Rashed HM; Bendas ER
    Drug Deliv; 2016 Nov; 23(9):3374-3386. PubMed ID: 27128792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of submicron emulsion as vehicles for rapid-onset intranasal delivery and improvement in brain targeting of zolmitriptan.
    Yu C; Gu P; Zhang W; Cai C; He H; Tang X
    Drug Deliv; 2011 Nov; 18(8):578-85. PubMed ID: 21838542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of combinational intranasal drug delivery system for the management of migraine by using statistical design.
    Kumar A; Garg T; Sarma GS; Rath G; Goyal AK
    Eur J Pharm Sci; 2015 Apr; 70():140-51. PubMed ID: 25676136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and evaluation of optimized zolmitriptan niosomal emulgel.
    Mohamed MI; Abdelbary AA; Kandil SM; Mahmoud TM
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1157-1167. PubMed ID: 30919700
    [No Abstract]   [Full Text] [Related]  

  • 6. Poloxamer 407-based intranasal thermoreversible gel of zolmitriptan-loaded nanoethosomes: formulation, optimization, evaluation and permeation studies.
    Shelke S; Shahi S; Jalalpure S; Dhamecha D
    J Liposome Res; 2016 Dec; 26(4):313-23. PubMed ID: 26758957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic study and brain tissue analysis of Zolmitriptan loaded chitosan nanoparticles in rats by LC-MS method.
    Khezri FANZ; Lakshmi CSR; Bukka R; Nidhi M; Nargund SL
    Int J Biol Macromol; 2020 Jan; 142():52-62. PubMed ID: 31593739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of olmesartan medoxomil optimized nanosuspension using the Box-Behnken design to improve oral bioavailability.
    Nagaraj K; Narendar D; Kishan V
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1186-1196. PubMed ID: 28271908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and optimization of boswellic acid-loaded proniosomal gel.
    Mehta M; Dureja H; Garg M
    Drug Deliv; 2016 Oct; 23(8):3072-3081. PubMed ID: 26953869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion.
    Abdou EM; Kandil SM; Miniawy HMFE
    Int J Pharm; 2017 Aug; 529(1-2):667-677. PubMed ID: 28729175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivariate Optimization of Rizatriptan Benzoate-Loaded Solid Lipid Nanoparticles for Brain Targeting and Migraine Management.
    Girotra P; Singh SK
    AAPS PharmSciTech; 2017 Feb; 18(2):517-528. PubMed ID: 27126007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug in Adhesive Patch of Zolmitriptan: Formulation and In vitro /In vivo Correlation.
    Liu C; Fang L
    AAPS PharmSciTech; 2015 Dec; 16(6):1245-53. PubMed ID: 25771739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting.
    Gavini E; Rassu G; Ferraro L; Beggiato S; Alhalaweh A; Velaga S; Marchetti N; Bandiera P; Giunchedi P; Dalpiaz A
    Eur J Pharm Biopharm; 2013 Feb; 83(2):174-83. PubMed ID: 23153670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of zolmitriptan-chitosan microparticles by spray drying for nasal delivery.
    Alhalaweh A; Andersson S; Velaga SP
    Eur J Pharm Sci; 2009 Oct; 38(3):206-14. PubMed ID: 19616094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
    Dudhipala N; Janga KY
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Box-Behnken design in understanding the quality of genistein self-nanoemulsified drug delivery systems and optimizing its formulation.
    Zhu S; Hong M; Liu C; Pei Y
    Pharm Dev Technol; 2009; 14(6):642-9. PubMed ID: 19883253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of zolmitriptan submicron emulsion for rapid and effective nasal absorption in beagle dogs.
    Yu C; Gu P; Zhang W; Qi N; Cai C; He H; Tang X
    Drug Dev Ind Pharm; 2011 Dec; 37(12):1509-16. PubMed ID: 21671836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of self-microemulsifying drug delivery system for telmisartan using Box-Behnken design and desirability function.
    Cho HJ; Lee DW; Marasini N; Poudel BK; Kim JH; Ramasamy T; Yoo BK; Choi HG; Yong CS; Kim JO
    J Pharm Pharmacol; 2013 Oct; 65(10):1440-50. PubMed ID: 24028611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality by Design Approach for Preparation of Zolmitriptan/Chitosan Nanostructured Lipid Carrier Particles - Formulation and Pharmacodynamic Assessment.
    Awadeen RH; Boughdady MF; Meshali MM
    Int J Nanomedicine; 2020; 15():8553-8568. PubMed ID: 33173292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and evaluation of chitosan-chondroitin sulphate based nasal inserts for zolmitriptan.
    Kaur K; Kaur G
    Biomed Res Int; 2013; 2013():958465. PubMed ID: 24175310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.